An anti-obesity drug that has been prescribed to 97,000 people in the UK doubled the risk of psychiatric disorders in those who took it, the European Medicines Agency has found.--from "Users of slimming drug at risk of psychiatric disorders" in the TIMES ONLINE.
The EMA has decided that the benefits of the drug Acomplia - which has been licensed in Europe since June 2006 - no longer outweigh the risks, and have advised doctors to no longer prescribe the drug.
In a trial of 36,000 this summer, five of those taking the drug committed suicide, compared to only one of those taking the placebo.
(And the above is just one reason why this Princess stays away from diet drugs, period. Remember Fen-Phen?)
~
No comments:
Post a Comment